Cargando…
Prophylactic nimodipine treatment for hearing preservation after vestibular schwannoma surgery: study protocol of a randomized multi-center phase III trial—AkniPro 2
BACKGROUND: A previously performed phase III trial on 112 subjects investigating prophylactic nimodipine treatment in vestibular schwannoma (VS) surgery showed no clear beneficial effects on preservation of facial and cochlear nerve functions, though it should be considered that protection of facial...
Autores principales: | Scheller, Christian, Strauss, Christian, Leisz, Sandra, Hänel, Pia, Klemm, Ariane, Kowoll, Simone, Böselt, Iris, Rahne, Torsten, Wienke, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8296656/ https://www.ncbi.nlm.nih.gov/pubmed/34294114 http://dx.doi.org/10.1186/s13063-021-05417-z |
Ejemplares similares
-
Prophylactic nimodipine treatment improves hearing outcome after vestibular schwannoma surgery in men: a subgroup analysis of a randomized multicenter phase III trial
por: Scheller, Christian, et al.
Publicado: (2020) -
Recurrences and progression following microsurgery of vestibular schwannoma
por: Scheer, Maximilian, et al.
Publicado: (2023) -
Vestibular Schwannoma Volume and Tumor Growth Correlates with Macrophage Marker Expression
por: Leisz, Sandra, et al.
Publicado: (2022) -
Nimodipine Treatment Protects Auditory Hair Cells from Cisplatin-Induced Cell Death Accompanied by Upregulation of LMO4
por: Fritzsche, Saskia, et al.
Publicado: (2022) -
Optimized preoperative determination of nerve of origin in patients with vestibular schwannoma
por: Rahne, Torsten, et al.
Publicado: (2021)